Bronchogen
Also known as: Ala-Glu-Asp, Lung Bioregulator
A short bioregulatory peptide targeting bronchial and lung tissue. Part of the Khavinson peptide bioregulators developed at the St. Petersburg Institute of Bioregulation.
Mechanism of Action
Gene expression regulation in bronchial epithelial cells, improving mucosal immunity, reducing inflammation, and normalizing bronchial secretion.
Dosing Protocol
Oral: 10-20 mg daily for 10-30 days. Subcutaneous: 1mg daily.
Open peptide calculatorReconstitution
20mg vial + 2mL BAC water for injection.
Storage
Room temperature (capsules). Lyophilized: -20°C.
Side Effects
- ●Generally well-tolerated
- ●Rare mild GI discomfort
Key Research Findings
- ●Improved respiratory function in COPD patients (Khavinson studies)
- ●Normalized bronchial epithelial gene expression in aging models
- ●Reduced frequency of respiratory infections in elderly subjects
Latest Verified Lab Report
No lab reports available for Bronchogen yet.
Community-funded testing results will appear here.
Vendor Trust Leaderboard
Trust leaderboard coming soon.
Vendor rankings based on verified lab test results.
Active Deals
15% off with code at checkout.
10% off with code at checkout.
10% off — discount applied automatically via referral link.
10% off with code at checkout.
Sponsored Ad Space
Advertise with usResearch Use Only
This information is provided for educational and research purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before using any research compounds.